Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer.
- Resource Type
- Article
- Source
Journal of Chemotherapy (Taylor & Francis Ltd) . Dec2023, Vol. 35 Issue 8, p760-770. 11p.- Subject
- Language
- ISSN
- 1120-009X